目的：研究急性髓细胞白血病(aml)联合化疗药物的体外敏感性及化疗药物间的相互作用。
Objective: To study the sensitivity in vitro and the interaction of drugs in combination chemotherapy for acute myeloblastic leukemia (AML).
结论：FAK基因沉默能明显增强白血病细胞对化疗药物敏感性，提示FAK基因沉默有望成为白血病治疗的新策略。
CONCLUSION: FAK gene silencing promotes the efficacy of chemotherapeutic drug in leukemic cells, indicating that FAK gene silencing might be considered as a new therapeutic strategy for leukemia.
结果不同抗白血病药物对不同白血病病人个体的敏感性存在差异；对药物敏感的白血病细胞形态结构出现明显改变或死亡。
Results There is difference in sensitivity to anti leukemic drugs among different patients, the morphology and structure of the cells in the experimental group changed significantly or died.
应用推荐